Coherus BioSciences Inc (NAS:CHRS)
$ 2.12 -0.05 (-2.3%) Market Cap: 243.22 Mil Enterprise Value: 464.61 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q1 2023 Coherus BioSciences Inc Earnings Call Transcript

May 08, 2023 / 09:00PM GMT
Release Date Price: $8.14 (+10.30%)
Operator

Good day, and thank you for standing by. Welcome to the Coherus BioSciences Q1 2023 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker, Marek Ciszewski of Investor Relations for Coherus BioSciences. Please go ahead.

Marek Ciszewski
Coherus BioSciences, Inc. - SVP of IR

Thank you, Crystal, and good afternoon, everyone. And thank you for joining us. We issued a press release earlier today announcing our financial results for the first quarter of 2023. This release can be found on the Coherus BioSciences website and is also attached to our Form 8-K. .

Today's call includes forward-looking statements regarding Coherus' current expectations about future events. These statements include, but are not limited to, our ability to gain approval for multiple new products and launch them, the ability of the FDA to complete all required inspections in China or our BLA for toripalimab necessary for approval, expectations about demand, timing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot